nevirapine and dolutegravir

nevirapine has been researched along with dolutegravir in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Allavena, C; Billaud, E; Bouchez, S; Bouquié, R; Dailly, E; Deslandes, G; Grégoire, M; Hall, N; Hernando, H; Jolliet, P; Raffi, F; Reliquet, V	1
Allavena, C; André-Garnier, E; Billaud, E; Grégoire, M; Guimard, T; Hall, N; Jovelin, T; Khatchatourian, L; Le Guen, L; Morrier, M; Perré, P; Raffi, F; Reliquet, V; Rodallec, A; Volteau, C	1
Ban, JK; Bunko, A; de Wet, JJ; Eberg, M; Ling, J; McKimm, M; Verdier, G	1

Trials

1 trial(s) available for nevirapine and dolutegravir

Article	Year
Influence of nevirapine administration on the pharmacokinetics of dolutegravir in patients infected with HIV-1. The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:12 Topics: Adult; Aged; Anti-HIV Agents; Drug Interactions; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV-1; Humans; Male; Middle Aged; Nevirapine; Oxazines; Piperazines; Prospective Studies; Pyridones	2015

Other Studies

2 other study(ies) available for nevirapine and dolutegravir

Article	Year
Switching from abacavir/lamivudine plus nevirapine to abacavir/lamivudine/dolutegravir in virologically controlled HIV-infected adults (SWAD study). Medecine et maladies infectieuses, 2019, Volume: 49, Issue:7 Topics: Adult; Anti-HIV Agents; Dideoxynucleosides; Drug Combinations; Drug Interactions; Drug Substitution; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Oxazines; Pilot Projects; Piperazines; Prospective Studies; Pyridones; Time Factors; Viral Load	2019
A real-world observational retrospective cohort study of Canadian people living with HIV switching from nevirapine plus two nucleoside reverse transcriptase inhibitors to dolutegravir/lamivudine. International journal of antimicrobial agents, 2023, Volume: 62, Issue:2 Topics: Anti-HIV Agents; Canada; HIV Infections; Humans; Lamivudine; Nevirapine; Oxazines; Patient Acceptance of Health Care; Pyridones; Retrospective Studies; Reverse Transcriptase Inhibitors; Viral Load	2023

Article

Year

Switching from abacavir/lamivudine plus nevirapine to abacavir/lamivudine/dolutegravir in virologically controlled HIV-infected adults (SWAD study).

Medecine et maladies infectieuses, 2019, Volume: 49, Issue:7

Topics: Adult; Anti-HIV Agents; Dideoxynucleosides; Drug Combinations; Drug Interactions; Drug Substitution; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Oxazines; Pilot Projects; Piperazines; Prospective Studies; Pyridones; Time Factors; Viral Load

2019

A real-world observational retrospective cohort study of Canadian people living with HIV switching from nevirapine plus two nucleoside reverse transcriptase inhibitors to dolutegravir/lamivudine.

International journal of antimicrobial agents, 2023, Volume: 62, Issue:2

Topics: Anti-HIV Agents; Canada; HIV Infections; Humans; Lamivudine; Nevirapine; Oxazines; Patient Acceptance of Health Care; Pyridones; Retrospective Studies; Reverse Transcriptase Inhibitors; Viral Load

2023